Pharma Firms
Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business
Pharma export growth in FY20 down to single digit due to Covid: Pharmexcil
GSK to offload HUL stake worth Rs 26,000 cr in largest secondary sale
Ensure pharma units work smoothly amid Covid-19 lockdown: Govt to districts
Over 8,660 pharma firms claimed tax deduction during 2019-20: I-T dept

TCS bags $1.5-bn contract from US drug firm Walgreens Boots Alliance
Cipla plans to partner Ayushman Bharat; start dialogue with insurance firms
Biocon and Mylan launch Trastuzumab biosimilar Ogivri in US market
From Dr Reddy's to Cipla, pharma companies aren't out of the woods: Experts
From auto to banking, grumble of slowdown is getting louder for India Inc

Cipla urges govt to increase funds, ease policies for domestic pharma firms
Growth in US business likely to boost Q1 revenues of pharma companies
Pharma funds remain in poor health amid headwinds on compliance
Pharma companies are focusing on profitable brands, say analysts
Regulatory issues bridle pharma returns, USFDA scrutiny a major hurdle
US antitrust probe singes India's pharmaceutical firms; Sun Pharma falls 9%
Returns down from US generic drugs market for Indian pharma firms
Drugs for rare diseases, ones innovated in India to go out of price control
Lupin to Cipla, pharma firms on course to shed 'underperformer' tag in FY19
Soon, uniform inspection norms for pharma units; govt to form advisory body